SEMAPA SGPS NAM. O.N./ PTSEM0AM0004 /
27/06/2024 21:43:00 | Chg. +0.500 | Volume | Bid27/06/2024 | Demandez à27/06/2024 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
14.680EUR | +3.53% | - Chiffrre d'affaires: - |
14.680Bid taille: 340 | 14.700Ask la taille: 340 | 1.17 Mrd.EUR | 3.49% | 11.01 |
GlobeNewswire
02:48
LAKESIDE HOLDING LIMITED ANNOUNCES PRICING OF $6.75 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
02:22
CFIUS Approval Obtained for the Planned Merger of North American Stainless, Inc. and Haynes Internat...
GlobeNewswire
02:00
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
01:51
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
01:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
01:31
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
01:30
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
01:17
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
01:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
01:00
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
00:30
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
00:29
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page